Predictive Oncology (POAI) Revenue & Revenue Breakdown
Predictive Oncology Revenue Highlights
Latest Revenue (Y)
$1.78M
Latest Revenue (Q)
$419.65K
Main Segment (Y)
Pittsburgh
Main Geography (Y)
Skyline
Predictive Oncology Revenue by Period
Predictive Oncology Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.78M | 18.24% |
| 2022-12-31 | $1.51M | 5.97% |
| 2021-12-31 | $1.42M | 13.45% |
| 2020-12-31 | $1.25M | -11.28% |
| 2019-12-31 | $1.41M | -0.01% |
| 2018-12-31 | $1.41M | 115.57% |
| 2017-12-31 | $654.84K | 43.45% |
| 2016-12-31 | $456.50K | -30.24% |
| 2015-12-31 | $654.35K | -31.23% |
| 2014-12-31 | $951.56K | 103.27% |
| 2013-12-31 | $468.13K | 147.98% |
| 2012-12-31 | $188.77K | 95.34% |
| 2011-12-31 | $96.64K | 33454.51% |
| 2010-12-31 | $288.00 | -98.17% |
| 2009-12-31 | $15.74K | 100.00% |
| 2008-12-31 | - | - |
Predictive Oncology generated $1.78M in revenue during NA 2023, up 18.24% compared to the previous quarter, and up 126.10% compared to the same period a year ago.
Predictive Oncology Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $419.65K | 25.26% |
| 2023-12-31 | $335.03K | -53.15% |
| 2023-09-30 | $715.06K | 45.90% |
| 2023-06-30 | $490.11K | 104.30% |
| 2023-03-31 | $239.90K | -34.00% |
| 2022-12-31 | $363.47K | -20.26% |
| 2022-09-30 | $455.83K | 22.67% |
| 2022-06-30 | $371.59K | 18.13% |
| 2022-03-31 | $314.57K | -33.98% |
| 2021-12-31 | $476.49K | 51.91% |
| 2021-09-30 | $313.66K | -10.43% |
| 2021-06-30 | $350.21K | 24.93% |
| 2021-03-31 | $280.32K | -4.59% |
| 2020-12-31 | $293.79K | -38.89% |
| 2020-09-30 | $480.76K | 163.02% |
| 2020-06-30 | $182.78K | -38.03% |
| 2020-03-31 | $294.94K | -15.12% |
| 2019-12-31 | $347.48K | -33.52% |
| 2019-09-30 | $522.70K | 82.66% |
| 2019-06-30 | $286.15K | 12.11% |
| 2019-03-31 | $255.24K | -18.07% |
| 2018-12-31 | $311.55K | -5.57% |
| 2018-09-30 | $329.93K | -7.99% |
| 2018-06-30 | $358.59K | -12.88% |
| 2018-03-31 | $411.59K | 86.82% |
| 2017-12-31 | $220.31K | 44.43% |
| 2017-09-30 | $152.53K | 42.79% |
| 2017-06-30 | $106.82K | -39.02% |
| 2017-03-31 | $175.17K | 25.51% |
| 2016-12-31 | $139.56K | 3.68% |
| 2016-09-30 | $134.60K | 57.58% |
| 2016-06-30 | $85.42K | -11.85% |
| 2016-03-31 | $96.91K | -47.13% |
| 2015-12-31 | $183.28K | 113.63% |
| 2015-09-30 | $85.79K | -63.34% |
| 2015-06-30 | $234.01K | 54.69% |
| 2015-03-31 | $151.27K | -8.76% |
| 2014-12-31 | $165.79K | -58.27% |
| 2014-09-30 | $397.25K | 24.81% |
| 2014-06-30 | $318.29K | 353.28% |
| 2014-03-31 | $70.22K | -14.06% |
| 2013-12-31 | $81.71K | -24.23% |
| 2013-09-30 | $107.83K | -28.52% |
| 2013-06-30 | $150.86K | 18.11% |
| 2013-03-31 | $127.73K | 42.61% |
| 2012-12-31 | $89.56K | 73.52% |
| 2012-09-30 | $51.62K | 106.79% |
| 2012-06-30 | $24.96K | 10.27% |
| 2012-03-31 | $22.64K | -69.41% |
| 2011-12-31 | $74.00K | 265.17% |
| 2011-09-30 | $20.26K | 753.58% |
| 2011-06-30 | $2.37K | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | -100.00% |
| 2010-03-31 | $288.00 | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | -100.00% |
| 2009-06-30 | $15.74K | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | - |
Predictive Oncology generated $419.65K in revenue during Q1 2024, up 25.26% compared to the previous quarter, and up 115.45% compared to the same period a year ago.
Predictive Oncology Revenue Breakdown
Predictive Oncology Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Pittsburgh | $492.60K | - | - | - | - |
| Helomics Segment | - | $6.40K | $13.37K | $64.19K | $48.45K |
| zPREDICTA | - | $352.38K | $90.00 | - | - |
| Soluble | - | $82.30K | $233.29K | $2.87K | - |
| Skyline | - | $1.06M | $1.17M | $1.19M | - |
| International | - | - | - | - | $88.07K |
| Domestic | - | - | - | - | $1.28M |
Predictive Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pittsburgh (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pittsburgh | $67.25K | $4.86K | $51.03K | $417.10K | $13.84K | $10.63K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Helomics Segment | - | - | - | - | - | - | $854.00 | $1.82K | $84.00 | $3.64K | $2.05K | $2.16K | $7.16K | $1.99K | $30.31K | $9.70K | $9.05K | $15.13K | - | - |
| zPREDICTA | - | - | - | - | - | - | $91.28K | $170.82K | $71.94K | $18.34K | - | - | - | - | - | - | - | - | - | - |
| Soluble | - | - | - | - | - | - | $17.72K | $29.44K | $22.23K | $12.92K | $156.65K | $27.65K | $34.91K | $14.07K | - | - | - | - | - | - |
| Skyline | - | - | - | - | - | - | $253.62K | $253.75K | $276.85K | $279.27K | $316.75K | $282.68K | $306.14K | $264.25K | $260.61K | $471.05K | - | - | - | - |
| Domestic | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $173.74K | $279.81K | $340.43K | $455.88K |
| International | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.02K | $40.01K |
| Other Segments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $26.81K |
Predictive Oncology's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Pittsburgh (100.00%).
Predictive Oncology Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 19 |
|---|---|---|
| zPREDICTA | $352.38K | - |
| Helomics Segment | $6.40K | - |
| Skyline | $1.06M | - |
| Soluble | $82.30K | - |
| Domestic | - | $1.28M |
Predictive Oncology's latest annual revenue breakdown by geography, as of Dec 22: Skyline (70.68%), zPREDICTA (23.42%), Soluble (5.47%), and Helomics Segment (0.43%).
Quarterly Revenue by Country
| Country | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|
| Domestic | $173.74K | $279.81K | $340.43K | $455.88K | $259.08K | $219.66K | - | - |
| Non-US | - | - | - | - | - | - | $4.20K | $3.18K |
Predictive Oncology's latest quarterly revenue breakdown by geography, as of Jun 20: Domestic (100.00%).
Predictive Oncology Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ISRG | Intuitive Surgical | $7.12B | $2.01B |
| PDEX | Pro-Dex | $53.84M | $14.29M |
| BNGO | Bionano Genomics | $36.12M | $7.77M |
| DXR | Daxor | $34.59M | $36.35M |
| ZJYL | Jin Medical | $19.82M | $9.57M |
| GMVD | G Medical Innovations | $4.42M | $-128.35K |
| NYXH | Nyxoah | $4.30M | $1.22M |
| NXGL | NEXGEL | $4.09M | $1.44M |
| POAI | Predictive Oncology | $1.78M | $419.65K |
| LUCY | Innovative Eyewear | $1.15M | $308.68M |
| GCTK | GlucoTrack | - | - |
| MBOT | Microbot Medical | - | - |
| STSS | Sharps | - | - |
POAI Revenue FAQ
What is Predictive Oncology’s yearly revenue?
Predictive Oncology's yearly revenue for 2023 was $1.78M, representing an increase of 18.24% compared to 2022. The company's yearly revenue for 2022 was $1.51M, representing an increase of 5.97% compared to 2021. POAI's yearly revenue for 2021 was $1.42M, representing an increase of 13.45% compared to 2020.
What is Predictive Oncology’s quarterly revenue?
Predictive Oncology's quarterly revenue for Q1 2024 was $419.65K, a 25.26% increase from the previous quarter (Q4 2023), and a 74.93% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $335.03K, a -53.15% decrease from the previous quarter (Q3 2023), and a -7.82% decrease year-over-year (Q4 2022). POAI's quarterly revenue for Q3 2023 was $715.06K, a 45.90% increase from the previous quarter (Q2 2023), and a 56.87% increase year-over-year (Q3 2022).
What is Predictive Oncology’s revenue growth rate?
Predictive Oncology's revenue growth rate for the last 3 years (2021-2023) was 25.30%, and for the last 5 years (2019-2023) was 26.11%.
What are Predictive Oncology’s revenue streams?
Predictive Oncology's revenue streams in c 23 are Pittsburgh
What is Predictive Oncology’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Predictive Oncology was Pittsburgh. This segment made a revenue of $492.6K, representing 100.00% of the company's total revenue.